Tarusan, Nedzfar M.
HRN: 24-88-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/17/2024
04/24/2024
IVT
350mg
Q6hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes